This topic contains a solution. Click here to go to the answer

Author Question: A patient with Parkinson's disease is taking levodopa/carbidopa (Sinemet) and reports occasional ... (Read 125 times)

stock

  • Hero Member
  • *****
  • Posts: 573
A patient with Parkinson's disease is taking levodopa/carbidopa (Sinemet) and reports occasional periods of loss of drug effect lasting from minutes to several hours.
 
  The nurse questions the patient further and discovers that these episodes occur at different times related to the medication administration. The nurse will contact the provider to discuss:
  a. administering a catechol-O-methyltransferase (COMT) inhibitor, such as entacapone.
  b. adding the DA-releasing agent amantadine to the regimen.
  c. giving a direct-acting dopamine agonist.
  d. shortening the dosing interval of levodopa/carbidopa.

Question 2

A group of nursing students asks a nurse to explain the blood-brain barrier. The nurse would be correct to say that the blood-brain barrier:
 
  a. prevents some potentially toxic substances from crossing into the central nervous system.
  b. causes infants to be less sensitive to CNS drugs and thus require larger doses.
  c. allows only ionized or protein-bound drugs to cross into the central nervous system.
  d. prevents lipid-soluble drugs from entering the central nervous system.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

raenoj

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

ANS: A
This patient is describing abrupt loss of effect, or the off phenomenon, which is treated with entacapone or another COMT inhibitor. Amantadine is used to treat dyskinesias. A direct-acting dopamine agonist is useful for gradual loss of effect, which occurs at the end of the dosing interval as the dose is wearing off. Shortening the dosing interval does not help with abrupt loss of effect.

Answer to Question 2

ANS: A
The blood-brain barrier can prevent some drugs and some toxic substances from entering the CNS. The blood-brain barrier in infants is not fully developed, so infants are more sensitive to CNS drugs and often require lower doses. The blood-brain barrier prevents highly ionized and protein-bound drugs from crossing into the CNS and allows lipid-soluble drugs and those that can cross via specific transport systems to enter.




stock

  • Member
  • Posts: 573
Reply 2 on: Jul 23, 2018
:D TYSM


aliotak

  • Member
  • Posts: 326
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

The calories found in one piece of cherry cheesecake could light a 60-watt light bulb for 1.5 hours.

Did you know?

The largest baby ever born weighed more than 23 pounds but died just 11 hours after his birth in 1879. The largest surviving baby was born in October 2009 in Sumatra, Indonesia, and weighed an astounding 19.2 pounds at birth.

Did you know?

A strange skin disease referred to as Morgellons has occurred in the southern United States and in California. Symptoms include slowly healing sores, joint pain, persistent fatigue, and a sensation of things crawling through the skin. Another symptom is strange-looking, threadlike extrusions coming out of the skin.

Did you know?

More than 150,000 Americans killed by cardiovascular disease are younger than the age of 65 years.

Did you know?

According to research, pregnant women tend to eat more if carrying a baby boy. Male fetuses may secrete a chemical that stimulates their mothers to step up her energy intake.

For a complete list of videos, visit our video library